Sorry!! The article you are trying to read is not available now.
BioTech/Pharma
Log In
Bussiness News
Politics And Regulation
Markets
The Economy
Editor's Pick
Trading And Investing
Stocks
ETFs
Fixed Income
Currencies
Earnings
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Hoofy & Boo
Radio
From The Buzz & Banter
Daily Recap
MV Education center
Video
t3 live subscriptions
Buzz And Banter
Cooper's Market Report
Techstrat Report
The Options Strategist
Minyanville
All Biotech/pharma Articles
Get
FREE MINYANVILLE
Newsletters & Alerts
Biotech Stocks Continue to See Share Prices Jump on Catalysts
By
TM Meyer
Jul 30, 2013 9:00 am
But before getting involved in this sector, investors should remember that volatility is extremely high and proper diversification is critical.
Read this article
Best Stocks: Isis, Gilead, Celgene, and Regeneron Take Over the Top Ranks
StateOfTheMarkets.com
New Analytic Tools Fuel Growth in Personal Medicine
Peter Pham
What's Behind Berkshire Hathaway Inc's Big DaVita Buy?
Valorie Sands
Stevia First Corp Set to Become Leader In Non-Caloric Beverage Industry
TM Meyer
Phillip Frost Buys More Shares of Opko Health, While Keynote Systems Sees a Sale
Jonathan Moreland
NeoStem Inc: A Stem Cell Company With an Attractive Valuation
TM Meyer
Recommendations
Archive
March, 2018
February, 2018
January, 2018
December, 2017
November, 2017
October, 2017
September, 2017
August, 2017
July, 2017
June, 2017
May, 2017
April, 2017
TICKERS
PFE
MRK
JNJ
BMY
GSK
DNDN
GILD
VRTX
AMGN
LLY
ARNA
BIIB
See All Tickers »